Japan· JP-2492414P2025
インスリンリスプロ（遺伝子組換え）
A medicinal product containing インスリンリスプロ（遺伝子組換え）, registered in Japan by 日本イーライリリー, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- インスリンリスプロ（遺伝子組換え）
- Manufacturer
- 日本イーライリリー
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
インスリンリスプロ（遺伝子組換え） in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAdmelog 100units/ml solution for injection 10ml vialsSanofi
- CzechiaBYSUMLOGGan & Lee Pharmaceuticals Europe GmbH, Düsseldorf
- United StatesADMELOGREMEDYREPACK INC.
- FinlandBysumlogGan & Lee Pharmaceuticals Europe GmbH
- BelgiumBysumlog 100 U/mlGan & Lee Pharmaceuticals Europe
- SwedenBysumlog 100 E/ml Injektionsvätska, lösning i förfylld injektionspennaSandoz GmbH
- IcelandBysumlogGan & Lee Pharmaceuticals Europe GmbH
- NetherlandsBysumlog 100 eenheden/ml oplossing voor injectie in een voorgevulde penGan & Lee Pharmaceuticals Europe GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bysumlog, Humalog
- Liechtenstein · Bysumlog, Humalog
- Norway · Bysumlog, Humalog
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3fcf371-d83d-4a41-a91b-14b52a266f6c GET /v1/drugs/d3fcf371-d83d-4a41-a91b-14b52a266f6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "３００単位１キット",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2492414P2025",
"category": "注射薬",
"price_yen": 1293,
"generic_name": "インスリンリスプロ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "2492",
"transitional_expiry": null
}See everything about インスリンリスプロ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.